Learn more about our appointment options, second opinions, locations, referrals, and resources.
Our cardio-oncology program treats people with cancer who are at risk of cardiotoxicity — a heart condition caused by cancer treatments, like radiation, chemo- and immunotherapy, hormone-based therapies, and other cancer treatments.
Part of the larger AHN Heart Disease Prevention Program, Cardio-Oncology Clinic specialists partner with oncologists at the AHN Cancer Institute to provide personalized cardiovascular care to cancer patients. Together, we help make sure your heart stays healthy before, during, and after receiving cancer treatments.
The AHN Cardio-Oncology Clinic monitors and treats patients who have an existing heart disease or are at risk of having heart disease prior to, during, and after receiving cancer treatments. Our team of specialists works closely with oncologists to provide a comprehensive treatment plan for your best care. An oncologist may refer you to our clinic while you receive treatment. If you’ve been diagnosed with cancer, ask your oncologist to see if you meet the cardio-oncology referral criteria through our programs.
Our Cardio-Oncology Clinic advises on how cancer treatments can be adjusted to help minimize the risk of treatment-related heart complications. Our team of expert-trained specialists uses the latest evidence and protocols, which includes blood tests for cardiac markers and imaging tests such as MRI, echocardiography with strain imaging, and nuclear MUGA scans to diagnose cardiac adverse effects early on. We coordinate our treatment plans with your oncologist to make sure you can continue safely with cancer treatment.
Our Cancer Institute also offers a Cancer Survivorship Program, which includes specialized care for long-term side effects from cancer treatments. By focusing on a patient's ongoing recovery, the program provides ongoing follow-ups and care for cardiotoxicity, as well as non-cardiology-related services like oncology rehabilitation. We're always testing the latest therapies that can help treat adverse cardiac side effects.
The Cardio-Oncology Clinic offers a number of services for patients diagnosed with cancer, including:
Depending on the type of heart disease and cancer treatment plan, our treatment options may include:
Our team of specialists is dedicated to treating cardiotoxicity and making sure your heart stays healthy before, during, and after cancer treatment.
At the AHN Cardio-Oncology Clinic, you'll work with:
Cardiovascular Disease
Cardiovascular Disease
Cardiovascular Disease
Cardiology
Jasmin M Martinez Castellanos, MD, FACC
Cardiovascular Disease
Cardiology
If you’ve been diagnosed with cancer and are looking for testing options, treatment plans, or long-term support for cardiotoxicity, we’re here to help you get the individualized care you need.
If you're looking for a second opinion, contact the Cardio-Oncology Clinic directly by calling the applicable location listed below.
If you’re experiencing symptoms or have been diagnosed with cancer, talk with your PCP about your options. Your doctor may refer you to one of our Cardio-Oncology Clinic locations for cardiotoxicity testing and treatment. You can call (412) DOCTORS (412) 362-8677 for a self-referral to discuss your health concerns.
To schedule an appointment for testing or treatment, please call Allegheny General Hospital (412) 359-4744, Wexford Health + Wellness Pavilion (878) 332-4214, or Saint Vincent Consultants in Cardiovascular Disease (814) 453-7767. Before calling, please have your current insurance information on hand. We also provide video visits for patients who don’t live near one of our three cardio-oncology clinic locations.
From testing to treatment plans, AHN provides quality care for patients with cardiotoxicity at the following locations:
Allegheny General Hospital
320 East North Avenue
Pittsburgh, PA 15212
GET DIRECTIONS
Saint Vincent Consultants
in Cardiovascular Disease
2315 Myrtle Street Suite 190
Erie, PA 16502
GET DIRECTIONS
Wexford Health + Wellness Pavilion
12311 Perry Highway
Wexford, PA 15090
GET DIRECTIONS
AHN’s Cardiovascular Research Institute is established on more than 100 years of innovation with diverse areas of focus, including research for the latest in cardiotoxicity testing and treatment. Our qualified team and Cardio-Oncology Clinic physicians take pride in using state-of-the-art technology and therapies to help revolutionize care for cardiotoxicity.
Clinical trials are special research opportunities that explore medical treatments, strategies, or devices to ensure they’re safe and effective for humans.
By prioritizing research and innovation, our physicians and patients are engaged in more than 100 national and international clinical trials. Participating in these trials gives AHN patients special access to some of the potential treatment options for cardiotoxicity.
To express interest in a clinical trial or to learn more about research opportunities, check out our active clinical trials. Participation in clinical trials is based on meeting eligibility criteria.
Non-AHN providers can submit an online patient referral or by calling (844) MD-REFER (844) 637-3337.
Non-AHN providers can use the EpicCare® Link™ platform to view updates on their patients’ care within AHN after the initial referral is completed.
If you need access to specific test results or imaging not provided in the EpicCare Link platform, please fill out a medical record request form.
EpicCare® is a registered trademark of Epic Systems Corporation and used with permission.
EpicCare® Link™ is a trademark of Epic Systems Corporation and used with permission.
Learn more about our appointment options, second opinions, locations, referrals, and resources.